Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-448-4 | CAS number: 95-76-1
Toxicological information
Skin sensitisation
Currently viewing:
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 3,4-dichloroaniline
- EC Number:
- 202-448-4
- EC Name:
- 3,4-dichloroaniline
- Cas Number:
- 95-76-1
- Molecular formula:
- C6H5Cl2N
- IUPAC Name:
- 3,4-dichloroaniline
- Details on test material:
- - Name of test material (as cited in study report): Dichloranilin, rein
- Physical state: solid, liquid after melting at 80°C
- Analytical purity: 99.2 %
- Purity test date: 1989-05-17
- Lot/batch No.: 243
- Expiration date of the lot/batch: 1990-03-23
- Stability under test conditions: tested and approved
- Storage condition of test material: dark, 21- 26°C
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: DHPW, SPF
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Age at study initiation: 5 to 8 weeks
- Weight at study initiation: 313 to 428 g
- Housing: 5 animals per Macrolon cage type VI
- Diet: ad libitum, Altromin 3022
- Water: ad libitum, tap water
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): approx. 50
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- propylene glycol
- Concentration / amount:
- intradermal induction 2.5 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous induction 50 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous challenge 50 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous rechallenge 25 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous rechallenge 5 % (w/w) 3,4-dichloroaniline in propylene glycol
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- propylene glycol
- Concentration / amount:
- intradermal induction 2.5 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous induction 50 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous challenge 50 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous rechallenge 25 % (w/w) 3,4-dichloroaniline in propylene glycol
epicutaneous rechallenge 5 % (w/w) 3,4-dichloroaniline in propylene glycol
- No. of animals per dose:
- two individual control groups: 10 animals each
one test group: 20 animals - Details on study design:
- RANGE FINDING TESTS: yes, one female guinea pig received intra dermal injections of 0, 1, 2.5 and 5 % 3,4-dichloroaniline in propylene glycol (w/w), all injection sites displayed redness after 24 and 48 h, the 5 % (w/w) injection site also became encrusted after 48 h. For the range finding for epicutaneous induction 4 female guineapigs received 3 occlusive gauze patchs with either 6, 12 or 25 % 3,4-dichloroaniline in propylene glycol for 24 h. No redness was observed after 48 and 72 h. 4 additional female guinea pigs then received occlusive gauze patchs with 50 % 3,4-dichloroaniline in propylene glycol for 24 h. Again no local irritation was observed after 48 and 72 h. Therefore the animals were pretreated with 10 % SDS in paraffine oil one day prior to epicutaneous induction to create a local irritation.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous)
- Exposure period: day 0 intradermal induction
day 7 epicutaneous induction for 48 h
- Control groups:
day 0: 1st injection, cranial, 0.1 mL, FCA : 0.9 % saline solution= 1 : 1
2nd injection, medial, 0.1 mL, propylene glycol
3rd injection, caudal, 0.1 mL, FCA : propylene glycol (w/w)= 1 : 1
day 6: epicutaneous treatment of the same areas with 0.2 mL 10 % SDS in paraffine oil
day 7: 3 occlusive gauze patches (2 x 4 cm) treated with 0.5 mL propylene glycol
- Test group:
day 0: 1st injection, cranial, 0.1 mL, FCA : 0.9 % saline solution= 1 : 1
2nd injection, medial, 0.1 mL, 2.5 % 3,4-dichloroaniline in propylene glycol (w/w)
3rd injection, caudal, 0.1 mL, FCA : 2.5 % 3,4-dichloroaniline in propylene glycol (w/w)= 1 : 1
day 6: epicutaneous treatment of the same areas with 0.2 mL 10 % SDS in paraffine oil
day 7: 3 occlusive gauze patches (2 x 4 cm) treated with 0.5 mL 50 % 3,4-dichloroaniline in propylene glycol (w/w)
B. CHALLENGE EXPOSURE
- No. of exposures: 3 ( epicutaneous)
- Day(s) of challenge: 3 and 4 weeks after intradermal induction
- Exposure period: 24 h
- Test groups:
challenge: 21st day, 1 occlusive gauze patch (2 x 4 cm) at the left flank treated
with 0.5 mL 50 % 3,4-dichloroaniline in propylene glycol (w/w)
rechallenge 28th day, 2 occlusive gauze patches (2 x 4 cm) at the left flank treated
with either 0.5 mL 25 % or 5 % 3,4-dichloroaniline in propylene glycol (w/w)
- Control group:
1st control group: 21st day, 1 occlusive gauze patch (2 x 4 cm) at the left flank treated
with 0.5 mL 50 % 3,4-dichloroaniline in propylene glycol (w/w)
2nd control group 28th day, 2 occlusive gauze patches (2 x 4 cm) at the left flank treated
with either 0.5 mL 25 % or 5 % 3,4-dichloroaniline in propylene glycol (w/w)
- Site: left flank challenge, right flank control (gauze patch treated with propylene glycol alone)
- Evaluation (hr after challenge): 48 and 72 h after challenge according to OECD guideline 406 - Challenge controls:
- see details on study design
- Positive control substance(s):
- yes
- Remarks:
- routinely checked by the testing laboratory, no further data
Study design: in vivo (LLNA)
- Statistics:
- no data
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- 9 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 9.0. Total no. in groups: 10.0. Clinical observations: 9 animals with discrete or patchy erythema.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- 15 animals with moderate to confluent erythema; 5 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: 15 animals with moderate to confluent erythema; 5 animals with discrete or patchy erythema.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 50 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Clinical observations:
- 7 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 50 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 7.0. Total no. in groups: 10.0. Clinical observations: 7 animals with discrete or patchy erythema.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 18
- Total no. in group:
- 20
- Clinical observations:
- 11 animals with discrete or patchy erythema, 4 animals with moderate and confluent erythema and 3 animals with intense erythema and swelling
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 18.0. Total no. in groups: 20.0. Clinical observations: 11 animals with discrete or patchy erythema, 4 animals with moderate and confluent erythema and 3 animals with intense erythema and swelling.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 8
- Total no. in group:
- 10
- Clinical observations:
- 7 animals with discrete or patchy erythema, 1 animal with moderate and confluent erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 8.0. Total no. in groups: 10.0. Clinical observations: 7 animals with discrete or patchy erythema, 1 animal with moderate and confluent erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 19
- Total no. in group:
- 20
- Clinical observations:
- 13 animals with discrete or patchy erythema, 6 animals with moderate and confluent erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 25 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 19.0. Total no. in groups: 20.0. Clinical observations: 13 animals with discrete or patchy erythema, 6 animals with moderate and confluent erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 25 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- 5 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 72.0. Group: negative control. Dose level: 25 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: 5 animals with discrete or patchy erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 25 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 17
- Total no. in group:
- 20
- Clinical observations:
- 17 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 72.0. Group: test group. Dose level: 25 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 17.0. Total no. in groups: 20.0. Clinical observations: 17 animals with discrete or patchy erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- 1 animal with dicrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 5 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: 1 animal with dicrete or patchy erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 14
- Total no. in group:
- 20
- Clinical observations:
- 14 animals with discrete or patchy erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 5 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 14.0. Total no. in groups: 20.0. Clinical observations: 14 animals with discrete or patchy erythema.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 5 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: negative control. Dose level: 5 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 5 % 3,4-dichloroaniline in propylene glycol
- No. with + reactions:
- 4
- Total no. in group:
- 20
- Clinical observations:
- 4 animals with discrete or patchy erythema
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 72.0. Group: test group. Dose level: 5 % 3,4-dichloroaniline in propylene glycol. No with. + reactions: 4.0. Total no. in groups: 20.0. Clinical observations: 4 animals with discrete or patchy erythema.
Any other information on results incl. tables
During the range finding test for the challenge concentration acute dermal toxicity was observed after simultaneous exposure of each of five guinea pigs to 4 occlusive gauze patches treated with either 0.5 mL 6, 12, 25 or 50 % 3,4 -dichloroaniline in propylene glycol.Two animals were found dead after 24 h and the remaining three were euthanized for animal welfare reasons due to severe signs of toxicity.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- Classification: sensitising
- Executive summary:
Diesing, L, 1990
3,4 -dichloroaniline was tested for skin sensitisation according to OECD guideline 406 in a Magnusson and Kligman test in male guinea pigs. Although irritation was also evident in the control group after challenge or rechallenge with either 50, 25 or 5 % 3,4 -dichloroaniline in propylene glycol (w/w) the incidence and severity of irritation was always higher in the induced test group. Therefore 3,4 -dichloroaniline was categorised as sensitising.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
